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C. M. GRUM, K. P. GALLAGHER, M. M. &RSH AND M. SHLAFER. Absence of Detectable Xanthine Oxidase in 
Human Myocardium. journal of Molecular and Cellular Cardiology (1989) 21, 263-267. The enzyme xanthine 
oxidase has been implicated as a generator of toxic oxygen metabolites that contribute to ischemic injury. 
Because substantial species variability has been demonstrated and because there are minimal human data 
available, the relevance of xanthine oxidase to human heart damage has been in doubt. We report the absence 
of xanthine oxidase activity in nine human heart biopsy specimens obtained during cardiac surgery, and in two 
larger samples obtained during heart transplantation. A sensitive radiochemical assay was used to assess enzyme 
activity. Our findings imply that oxygen free radicals generated by xanthine oxidase are not relevent in terms of 
human myocardial injury. 
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Introduction 
Toxic oxygen metabolites have been postu- 
lated to participate in acute ischemic and 
hypoxic myocardial injury (Chambers et al., 
1985 ; McCord, 1985). Although they may 
come from many sources, recent studies have 
emphasized the potential importance of 
xanthine oxidase which is formed from xanth- 
ine dehydrogenase during ischemia or 
hypoxia (McCord, 1985; Hearse et al., 1986; 
Parks and Granger, 1986). Indeed, inhibition 
of xanthine oxidase or limitation of substrate 
availability for the enzyme does minimize 
injury in some animal models. However, not 
all animal models conform to this scheme. In 
particular, we and others have shown that the 
ischemic/reperfused rabbit heart does not 
contain either xanthine oxidase or dehydroge- 
nase (Grum et al., 1986, 1987a; Downey et al., 
1988). ‘Therefore, it appears likely that the 
myocardial xanthine oxidase system may be 
more important in some species (e.g. dog, ratj 
than in others (e.g. rabbit, pig). Species varia- 
bility raises questions about the applicability 
of the xanthine oxidase hypothesis to human 
myocardium. The sparse human data avail- 
able have yielded conflicting results. Using a 
variety of enzyme assays and tissue sampling 
procedures, investigators have reported no 
xanthine oxidase activity (Ramboer, 1969; 
Eddy et al., 1987), minute levels of activity 
(Watts et al., 1965; Muxfeldt and Schaper, 
1987), or relatively high levels of activity 
(Bruder et al., 1984). Using a previously vali- 
dated sensitive radiochemical assay (Grum et 
al., 1986), we report the absence of measur- 
able xanthine oxidase or dehydrogenase activ- 
ity in human myocardium. 
Materials and Methods 
Human heart studies 
A protocol, including written informed 
consent documents, was submitted to and 
approved by the Human Use Committee at 
The University of Michigan (IRB 87-1393. 
We obtained a left ventricular myocardial 
biopsy from nine patients undergoing cardiac 
surgery. Each biopsy was obtained before 
aortic cross-clamping and the induction of 
Please address all correspondence to: Cyril M. Grum, The University of Michigan Medical Center, 3916 Tauhman 
Center, Box 0360, Ann Arbor, MI 48109-0360, USA. 
1022~2828/89/030263 + 05$03.00/O Q1989 Academic Press Limited 
264 C. M. Grum et al. 
global &hernia. The biopsies were obtained 
by a small cutting forceps, similar to those 
used for polypectomy during colonscopy. The 
biopsies were frozen within 10 s by immersion 
in liquid nitrogen, and stored at -80°C. Bio- 
psies were processed as described below. 
Rat heart studies 
To assess the ability of the enzyme assays to 
detect activity in small tissue samples, biopsies 
were obtained from the left ventricular myo- 
cardium of six Sprague-Dawley rats that were 
killed by decapitation. The hearts were imme- 
diately biopsied in situ with a forceps identical 
to that used for human hearts. Biopsies were 
frozen immediately in liquid nitrogen, stored, 
and processed as described below. 
Tissue preparation 
Frozen biopsies were weighed and imme- 
diately placed in 1 ml of an ice cold buffer 
(PH 9.0) containing 0.125 M 
Tris(hydroxymethyl)aminomethane, 10 mM 
dithiothreitol (DTT), 1 mM phenylmethylsul- 
fonyl fluoride (PMSF), and 0.1 mM EDTA. 
The DTT and PMSF were added to prevent 
in vitro conversion of xanthine dehydrogenase 
to xanthine oxidase. The tissue was homoge- 
nized in the ice cold buffer. The homogenate 
was spun at 12 000 g for 20 min at 4°C. The 
supernatant was dialyzed at 4°C in a 200 : 1 
dilution of buffer overnight to remove enzyme 
inhibitors and endogenous purines. Aliquots 
were then assayed for enzyme activity. 
Enzyme assg 
The radiochemical assay for xanthine 
oxidase/xanthine dehydrogenase is identical 
to that which we have described before 
(Grum et al., 1986). In brief, we optimized 
enzyme activity according to the method of 
Mousson et al. (1983). The reaction mixture 
contained buffer, [8-14C] hypoxanthine, and 
sample, at 37”C, in a shaking water bath. Six 
aliquots of each sample were reacted with the 
radiolabeled hypoxanthine in the presence or 
absence of NAD+ ( 1 mM final concentration), 
perchloric acid (283 mM), or allopurinol ( 1 
mM). This enabled us to assess, individually, 
the activities of xanthine oxidase alone, 
xanthine oxidase plus xanthine dehydroge- 
nase, pharmacologic inhibition by allopurin- 
01, and baseline counts. Sample counts W~I‘C 
adjusted by subtracting the background 
counts obtained in the perchloric acid-treated 
controls. The reaction was run for 15 min, 
since reaction rates become nonlinear there- 
after (Watts et al., 19651. All reactions were 
stopped by adding perchloric acid and imme- 
diately chilling the reaction mixtures in ice. 
The reaction mixture was spotted on electro- 
phoresis paper. Substrate and products were 
separated with high voltage electrophoresis. 
The spots were identified under U.V. light, cut. 
and radioactivity was counted by liquid scin- 
tillation spectrometry. Enzyme activity was 
computed and expressed as milliinternational 
units/g of wet tissue weight. One mIU corre- 
sponds to one nmol of hypoxanthine oxidized/ 
min. 
Results 
The nine human myocardial biopsies weighed 
13 f 2 mg (mean f s.E.M.). The rat heart 
biopsies weighed 13 k 1 mg (not significantly 
different from human biopsy weights; 
P > 0.8, t-test). No xanthine oxidase or 
xanthine dehydrogenase activity was detected 
in the human myocardial samples. Under 
conditions used to assay xanthine oxidase plus 
xanthine dehydrogenase activity of the 
human samples, the radioactivity of the elec- 
trophoresis spots containing xanthine plus 
uric acid did not exceed the background 
radioactivity. The corresponding activity 
measured under conditions to assess xanthine 
oxidase activity alone also did not exceed 
background radioactivity. The addition of 
allopurinol (1 mM) to both these assays had no 
effect. These findings indicate that there is no 
xanthine oxidase or xanthine dehydrogenase 
activity present in human myocardial samples 
based on this assay. 
In order to confirm our findings, we 
obtained larger pieces (150 and 589 mg) of 
human myocardium at the time of cardiac 
transplantation in two patients. This tissue 
was assayed using the same procedures used 
for the biopsies. There was no evidence of 
xanthine dehydrogenase or xanthine oxidase 
activity. 
In contrast, with rat myocardial samples, 
radioactivity of the xanthine and uric acid 
spots obtained under conditions measuring 
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Enzyme activity (mIU/g wet wt)* 
XO/XD x0 XD 
Rat heart biopsies (n = 6) 98.1 f 24.3 54.9 f 17.7 43.2 f 14.5 
Human heart biopsies (n = 9) 0 0 0 
Human heart transplant (n = 2) 0 0 0 
samples 
* XOjXD, combined xanthine oxidase and dehydrogenase activity; X0, xanthine oxidase 
activity; XD, xanthine dehydrogenase activity 
both xanthine oxidase and dehydrogenase 
exceeded background by 1281 + 308 ct/min 
(P < 0.001 ; t-test). The corresponding counts 
for xanthine oxidase alone exceeded back- 
ground by 682 f 132 ct/min (P < 0.001; 
t-testi. The counts per minute for rat myo- 
cardial samples run in the presence of allopu- 
rinol were not different from background 
counts (P > 0.4; t-test). This indicated that 
allopurinol completely inhibited xanthine 
oxidase activity. The computed enzyme activ- 
ities are shown in Table 1. Total enzyme 
activity joxidase plus dehydrogenase) was 
only slightly higher than that which we have 
previously reported for whole rat hearts (62 
mIU/g wet wt; Grum et al., 1986), or the 
value reported by Eddy et al. (1987 ; 77 
mIU/g wet wt). However, our microsampling 
technique resulted in a greater percentage of 
the enzyme in the oxidase form. We believe 
manipulation and processing of the small 
biopsies caused the increased conversion of 
xanthine oxidase to dehydrogenase. 
Discussion 
Our main finding is that we did not detect 
any xanthine oxidase or dehydrogenase activ- 
ity in human myocardial biopsies. This sup- 
ports the data of Eddy et al. (1987), that in 
terms of xanthine oxidase, human myocard- 
ium appears more similar to rabbit myocard- 
ium than to rat or dog myocardium. Our 
present study using a sensitive radiochemical 
assay corroborates the postulate of Downey et 
al. ( 1988)) that xanthine oxidase-mediated 
degradation of hypoxanthine is an important 
potential source of free radicals in the isch- 
emit myocardium of some, but not all, 
species. 
Previous efforts to measure xanthim 
oxidase in human myocardium have suffered 
from methodological difficulties and, not sur- 
prisingly from conflicting results. Watts el al. 
(1965) found minute levels (i.e. less than 1 
mIU/g protein) in two cadaver hearts. 
Ramboer (1969) could not detect any activity 
in a cadaveric sample. Cadaver values 
however may be influenced by preterminal 
release of xanthine oxidase into plasma from 
necrotic liver. More recently, Muxfeldt and 
Schaper (1987), using a standard spectropho- 
tometric assay, have reported barely detect- 
able (0.013 nmol/min/g wet wtj xanthinc 
oxidase activity in tissue from one human 
heart obtained during surgery. This level of 
activity is lower than that found in the hearts 
of other species with the exception of the 
rabbit heart. On the other hand, the prelimi- 
nary finding by deJong et al. (19871 that 
human heart can produce significant amounts 
of uric acid had led them to conclude that 
xanthine oxidase activity is present. Jarasch 
and coworkers have noted immunofluorescent 
staining of human myocardial capillaries 
using xanthine oxidase antibodies (Bruder et 
al., 1984; Jarasch et al., 1986). However, they 
used antibodies to milk xanthine oxidase, and 
human myocardium may possess an enzyme 
form that is neither xanthine oxidase nor 
dehydrogenase but can cross-react with the 
antibody (Downey et al., 1988). Jarasch and 
colleagues therefore did not report xanthine 
oxidase activity, but the presence of matertar 
that reacts to anti-bovine xanthine oxidase 
antibodies. The most convincing evidence for 
the lack of xanthine oxidase in human heart 
used a modified spectrophotometric assay 
(Eddy et al., 1987)) applied to heart samples 
from four patients. They used matched allo- 
purinol controls to compensate for the 
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unknown peak which coabsorbs with uric 
acid. We obtained the same outcome using a 
very sensitive radiochemical assay that has 
been thoroughly validated in the past, both 
by others (Mousson et al., 1983 ; Sinclair and 
Fox, 1975) and in our previous experiments 
(Grum et al., 1986). In addition, our methods 
for processing and analyzing the human myo- 
cardial biopsies were identical to those used 
for rat myocardial biopsies, a species charac- 
terized by relatively high levels of xanthine 
oxidase and dehydrogenase. 
Thus we concur that xanthine oxidase and 
xanthine dehydrogenase do not exist (or exist 
at very low concentrations) in the human 
myocardium. This enzyme system therefore is 
not likely to be important in ischemic/ 
reperfusion injury of the human heart. In 
choosing an experimental model of ischemia- 
reperfusion injury that realistically simulates 
human myocardial injury, we propose that a 
model devoid of xanthine oxidase may be the 
most appropriate. In rat and dog ischemic- 
reperfusion injury, xanthine oxidase gener- 
ation of oxygen radicals appears to play a 
major role. Data at this point suggests that the 
rabbit model, and possibly the pig model, 
may be the most rational option to examine 
human ischemic/reperfusion myocardial 
injury (Grum et al., 1986, 1987a; Muxfeldt 
and Schaper, 1987; Downey et al., 1988). 
Studies of the xanthine oxidase and dehydro- 
genase system may nonetheless be relevant to 
human disease. Xanthine oxidase and dehy- 
drogenase are present in human liver and 
small intestine in high concentrations 
(Mousson et al., 1983). In some forms of acute 
diffuse lung injury, and in acute liver injury, 
xanthine oxidase is present in human plasma 
and therefore could be transported to the 
myocardium (Shamma’a et al., 1965 ; Grum et 
al., 198713). Toxic oxygen metabolites could 
then be generated when the circulating xanth- 
ine oxidase reacts with the increased purines 
formed during ischemic myocardial episodes. 
In addition, human neutrophils may contain 
xanthine oxidase (Jones et al., 1985). Finally, 
studies of xanthine oxidase inhibitors, (e.<g. 
allopurinol) have shown beneficial effect on 
injury by a pathway not related to enzyme 
inhibition (Myers et al., 1985, 1986; Downey 
et al., 1988) 
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